Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas.
Majós
C
C
Department of Radiology, Institut de Diagnòstic per Imatge, Centre Bellvitge, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain. cmajos@bellvitgehospital.cat
Bruna
J
J
Julià-Sapé
M
M
Cos
M
M
Camins
A
A
Gil
M
M
Acebes
J J
JJ
Aguilera
C
C
Arús
C
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001254:Astrocytoma / Q000175:diagnosis* / Q000401:mortality*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000401:mortality*; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011379:Prognosis; D016016:Proportional Hazards Models; D011522:Protons; D015203:Reproducibility of Results; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013030:Spain / Q000453:epidemiology; D016019:Survival Analysis; D015996:Survival Rate
D011522:Protons